-
-
-
-
-
-
-
Immix Biopharma, Inc. (IMMX) PT Raised to $15 at Mizuho
-
-
-
-
-
-
-
Immix Biopharma, Inc. (IMMX) PT Raised to $12 at H.C. Wainwright
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Immix Biopharma, Inc. (IMMX)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Immix Biopharma, Inc. (IMMX)
-
-
-
-
-
-
-
Immix Biopharma (IMMX) Expands U.S. Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2
-
413,572 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

